CN101119976B - 抑制hiv的2-(4-氰基苯氨基)嘧啶氧化物衍生物 - Google Patents
抑制hiv的2-(4-氰基苯氨基)嘧啶氧化物衍生物 Download PDFInfo
- Publication number
- CN101119976B CN101119976B CN2006800053322A CN200680005332A CN101119976B CN 101119976 B CN101119976 B CN 101119976B CN 2006800053322 A CN2006800053322 A CN 2006800053322A CN 200680005332 A CN200680005332 A CN 200680005332A CN 101119976 B CN101119976 B CN 101119976B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- hiv
- acid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
化合物编号 | IIIB | A | B | C | D | E | F |
1 | 9.24 | 9.20 | 8.85 | 9.20 | 9.22 | 8.97 | 8.98 |
A | 8.55 | 8.00 | 8.75 | 8.54 | 8.61 | 8.09 | 8.34 |
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05101270.6 | 2005-02-18 | ||
EP05101270 | 2005-02-18 | ||
PCT/EP2006/060115 WO2006087387A1 (en) | 2005-02-18 | 2006-02-20 | Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101119976A CN101119976A (zh) | 2008-02-06 |
CN101119976B true CN101119976B (zh) | 2010-12-22 |
Family
ID=36570887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800053322A Expired - Fee Related CN101119976B (zh) | 2005-02-18 | 2006-02-20 | 抑制hiv的2-(4-氰基苯氨基)嘧啶氧化物衍生物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7935711B2 (zh) |
EP (1) | EP1853567B1 (zh) |
JP (1) | JP5247154B2 (zh) |
CN (1) | CN101119976B (zh) |
AU (1) | AU2006215599B2 (zh) |
BR (1) | BRPI0607811B8 (zh) |
ES (1) | ES2533258T3 (zh) |
MX (1) | MX2007010051A (zh) |
RU (1) | RU2398768C2 (zh) |
WO (1) | WO2006087387A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0720436A2 (pt) | 2006-12-13 | 2014-01-07 | Hoffmann La Roche | Inibidores de transcriptase reversa de não-nucleosídeo |
WO2010150279A2 (en) * | 2009-06-22 | 2010-12-29 | Emcure Pharmaceuticals Limited | Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor |
US8153790B2 (en) | 2009-07-27 | 2012-04-10 | Krizmanic Irena | Process for the preparation and purification of etravirine and intermediates thereof |
CN102648197A (zh) * | 2009-08-12 | 2012-08-22 | 铂雅制药公司 | 促进细胞凋亡和抑制转移的方法 |
CA2803848A1 (en) * | 2010-06-28 | 2012-01-05 | Hetero Research Foundation | A process for etravirine intermediate and polymorphs of etravirine |
CA2803004A1 (en) | 2010-06-29 | 2012-01-12 | Poniard Pharmaceuticals, Inc. | Oral formulations of kinase inhibitors |
WO2012012139A1 (en) | 2010-06-30 | 2012-01-26 | Poniard Pharmaceuticals, Inc. | Synthesis and use of kinase inhibitors |
EP2702044B1 (en) | 2011-04-25 | 2017-03-22 | Hetero Research Foundation | Process for rilpivirine |
ES2655525T3 (es) * | 2011-04-26 | 2018-02-20 | Mylan Laboratories Ltd. | Proceso novedoso para la preparación de Etravirina |
CA3158698A1 (en) | 2020-02-19 | 2021-08-26 | Alexander Vitalievich Kurkin | Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of hiv infection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000027825A1 (en) * | 1998-11-10 | 2000-05-18 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines |
WO2004002410A2 (en) * | 2002-06-27 | 2004-01-08 | Bristol-Myers Squibb Company | 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148801A0 (en) * | 1999-09-24 | 2002-09-12 | Janssen Pharmaceutica Nv | Antiviral compositions |
AR039540A1 (es) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
JP5046943B2 (ja) | 2004-09-30 | 2012-10-10 | テイボテク・フアーマシユーチカルズ | Hiv阻害性5−置換ピリミジン |
KR20070057899A (ko) | 2004-09-30 | 2007-06-07 | 티보텍 파마슈티칼즈 리미티드 | Hiv를 억제하는 5-헤테로사이클릴피리미딘 |
RU2403245C2 (ru) | 2005-01-27 | 2010-11-10 | Тиботек Фармасьютикалз Лтд. | Ингибирующие вич производные 2-(4-цианофениламино)пиримидина |
BRPI0609291B1 (pt) | 2005-03-04 | 2022-02-08 | Janssen Sciences Ireland Uc | 2-(4-ciano-fenil)-o-hidroxilamina-pirimidinas que inibem hiv, composição farmacêutica que as compreende e processo para a preparação de ambas |
KR20080114741A (ko) | 2006-03-30 | 2008-12-31 | 티보텍 파마슈티칼즈 리미티드 | Hiv를 억제하는 5-아미도 치환 피리미딘 |
MX2008012577A (es) | 2006-03-30 | 2008-10-10 | Tibotec Pharm Ltd | Pirimidinas sustituidas con 5-(hidroximetileno y aminometileno) que inhiben el virus de inmunodeficiencia humana. |
CN101573343B (zh) | 2006-12-29 | 2016-02-24 | 爱尔兰詹森科学公司 | 抑制人免疫缺陷病毒的6-取代的嘧啶 |
-
2006
- 2006-02-20 MX MX2007010051A patent/MX2007010051A/es active IP Right Grant
- 2006-02-20 ES ES06743193.2T patent/ES2533258T3/es active Active
- 2006-02-20 RU RU2007134564/04A patent/RU2398768C2/ru active
- 2006-02-20 WO PCT/EP2006/060115 patent/WO2006087387A1/en active Application Filing
- 2006-02-20 EP EP06743193.2A patent/EP1853567B1/en active Active
- 2006-02-20 CN CN2006800053322A patent/CN101119976B/zh not_active Expired - Fee Related
- 2006-02-20 JP JP2007555635A patent/JP5247154B2/ja active Active
- 2006-02-20 BR BRPI0607811A patent/BRPI0607811B8/pt not_active IP Right Cessation
- 2006-02-20 AU AU2006215599A patent/AU2006215599B2/en not_active Ceased
- 2006-02-20 US US11/814,958 patent/US7935711B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000027825A1 (en) * | 1998-11-10 | 2000-05-18 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting pyrimidines |
WO2004002410A2 (en) * | 2002-06-27 | 2004-01-08 | Bristol-Myers Squibb Company | 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
EP1853567A1 (en) | 2007-11-14 |
RU2007134564A (ru) | 2009-03-27 |
BRPI0607811B8 (pt) | 2021-05-25 |
BRPI0607811B1 (pt) | 2019-08-20 |
MX2007010051A (es) | 2007-09-21 |
US20080194602A1 (en) | 2008-08-14 |
WO2006087387A1 (en) | 2006-08-24 |
AU2006215599A1 (en) | 2006-08-24 |
AU2006215599B2 (en) | 2012-09-27 |
CN101119976A (zh) | 2008-02-06 |
EP1853567B1 (en) | 2014-12-31 |
BRPI0607811A2 (pt) | 2009-10-06 |
RU2398768C2 (ru) | 2010-09-10 |
ES2533258T3 (es) | 2015-04-08 |
JP5247154B2 (ja) | 2013-07-24 |
JP2008530184A (ja) | 2008-08-07 |
US7935711B2 (en) | 2011-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101119976B (zh) | 抑制hiv的2-(4-氰基苯氨基)嘧啶氧化物衍生物 | |
CN101107234B (zh) | 抑制hiv的2-(4-氰基苯氨基)嘧啶衍生物 | |
US10077270B2 (en) | HIV inhibiting bicyclic pyrimidine derivatives | |
CN101133038B (zh) | 抑制hiv的2-(4-氰基苯基)-6-羟氨基嘧啶 | |
CN1751031B (zh) | 抑制hiv复制的嘧啶 | |
CN101027288A (zh) | 抑制hiv的5-取代嘧啶 | |
CN101103029B (zh) | 作为抗感染剂的1,5,6-取代的-2-氧代-3-氰基-1,6a-二氮杂-四氢-荧蒽 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150727 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: JANSSEN R + D IRELAND Free format text: FORMER NAME: TIBOTEC PHARM LTD. Owner name: TIBOTEC PHARM LTD. Free format text: FORMER NAME: TIBOTEC NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: The Irish Village Patentee after: TIBOTEC PHARMACEUTICALS Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Ltd. Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150727 Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: JANSSEN R&D IRELAND |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 |
|
CF01 | Termination of patent right due to non-payment of annual fee |